PubRank

Enrico Mastrobattista

Author PubWeight™ 44.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum 2006 1.98
2 Directed evolution by in vitro compartmentalization. Nat Methods 2006 1.45
3 Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes. J Control Release 2012 1.39
4 Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine 2011 1.37
5 Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 2009 1.26
6 In vitro compartmentalization by double emulsions: sorting and gene enrichment by fluorescence activated cell sorting. Anal Biochem 2004 1.20
7 Nonnatural amino acids for site-specific protein conjugation. Bioconjug Chem 2009 1.18
8 How to screen non-viral gene delivery systems in vitro? J Control Release 2011 1.17
9 Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Vaccine 2008 1.12
10 The nuclear pore complex: the gateway to successful nonviral gene delivery. Pharm Res 2006 1.07
11 Targeting tumor antigens to dendritic cells using particulate carriers. J Control Release 2012 1.05
12 Self-assembly of recombinant amphiphilic oligopeptides into vesicles. Biomacromolecules 2007 1.02
13 Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells. Blood 2008 0.96
14 Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. J Control Release 2010 0.95
15 Identification of peptide ligands for targeting to the blood-brain barrier. Pharm Res 2010 0.90
16 Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds. Pharm Res 2009 0.90
17 OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochim Biophys Acta 2004 0.90
18 High-content screening of peptide-based non-viral gene delivery systems. J Control Release 2011 0.87
19 In vivo methods to study uptake of nanoparticles into the brain. Pharm Res 2010 0.87
20 Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes. Pharm Res 2008 0.86
21 Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration. Pharm Res 2009 0.86
22 Polymers for gene delivery: Charged for success. Nat Mater 2011 0.83
23 Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine. J Control Release 2010 0.83
24 Strategies for triggered drug release from tumor targeted liposomes. Expert Opin Drug Deliv 2013 0.83
25 Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy. Pharm Res 2006 0.83
26 Strategies for cytosolic delivery of liposomal macromolecules. Int J Pharm 2005 0.82
27 Nanotechnological approaches for the delivery of macromolecules. J Control Release 2003 0.82
28 Production and biomedical applications of virus-like particles derived from polyomaviruses. J Control Release 2013 0.81
29 Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine. Syst Synth Biol 2010 0.81
30 Trends in polymeric delivery of nucleic acids to tumors. J Control Release 2013 0.80
31 Optimization and quantification of protein synthesis inside liposomes. J Liposome Res 2010 0.80
32 DNA nuclear targeting sequences for non-viral gene delivery. Pharm Res 2011 0.80
33 Delivery of nucleic acids. Pharm Res 2007 0.78
34 Junk DNA enhances pEI-based non-viral gene delivery. Int J Pharm 2009 0.78
35 Targeted decationized polyplexes for siRNA delivery. Mol Pharm 2014 0.78
36 Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine. J Control Release 2009 0.77
37 Peptide nanocarriers for intracellular delivery of photosensitizers. J Control Release 2009 0.77
38 Coiled coil interactions for the targeting of liposomes for nucleic acid delivery. Nanoscale 2016 0.77
39 Decationized crosslinked polyplexes for redox-triggered gene delivery. J Control Release 2013 0.77
40 Peptide vectors for gene delivery: from single peptides to multifunctional peptide nanocarriers. Nanomedicine (Lond) 2014 0.76
41 A micelle-shedding thermosensitive hydrogel as sustained release formulation. J Control Release 2012 0.76
42 Decationized polyplexes for gene delivery. Expert Opin Drug Deliv 2014 0.76
43 A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine. Eur J Pharm Sci 2011 0.76
44 Attaching the phage display-selected GLA peptide to liposomes: factors influencing target binding. Eur J Pharm Sci 2011 0.76
45 Looped structure of flowerlike micelles revealed by 1H NMR relaxometry and light scattering. Langmuir 2011 0.76
46 A solid-phase platform for combinatorial and scarless multipart gene assembly. ACS Synth Biol 2013 0.76
47 Targeted decationized polyplexes for cell specific gene delivery. Bioconjug Chem 2014 0.76
48 Conformation and intermolecular interactions of SA2 peptides self-assembled into vesicles. J Phys Chem B 2010 0.76
49 Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants. Pharm Res 2013 0.75
50 ATRP, subsequent azide substitution and 'click' chemistry: three reactions using one catalyst in one pot. Chem Commun (Camb) 2011 0.75
51 Hemocompatibility assessment of two siRNA nanocarrier formulations. Pharm Res 2014 0.75
52 Preparation and characterization of liposomal formulations of neurotensin-degrading enzyme inhibitors. Int J Pharm 2011 0.75
53 Erratum: Making individualized drugs a reality. Nat Biotechnol 2017 0.75
54 Artificial microbes to fight cancer. Nanomedicine (Lond) 2013 0.75